일란성 쌍생아에서 혈액 및 종양 질환 치료 후 성장 및 정신신경학적 발달에 대한 비교연구 = Comparison of growth and neuropsychological function after treatment for hematologic and oncologic diseases in monozygotic twins

다국어 초록 (Multilingual Abstract)

Purpose : The primary purpose of this study was to evaluate the growth and neuropsychologic function following treatments for pediatric hematologic and oncologic diseases. Healthy monozygotic twins served as ideal controls for comparison to exclude possible confounding factors.
Methods : Seven children treated with various hematologic and oncologic diseases were included in the study: acute lymphoblastic leukemia (ALL; n=2), Diamond-Blackfan anemia twins (n=2), and aplastic anemia (n=3). The median age at the diagnosis was 5.2 (0.3-15) years. The median duration of follow-up was 7.2 (4.9-10) years. Controls were healthy monozygotic twins. Growth was measured and the percentile channels were evaluated sequentially for patients. The K-WISC III was applied and compared in 5 pairs of patients and controls.
Results : Similar growth profiles were noted for the twins. The percentiles at diagnosis was 3-10 in 3, 25-50 in 2, and 50-75 in 2 cases. All patients stayed in their growth percentiles through follow-up, except for 1 patient who became obese. For IQ tests, the mean behavioral, verbal and full scale IQ scores of patients were 88.0, 93.8, and 89.8, respectively, and those from their corresponding controls were 92.2, 97.0, and 91.7 (P>0.05). However, 2 children who were treated for ALL had lower IQ scores.
Conclusion : Similar growth profiles were observed in the monozygotic twins in terms of height and weight. The IQ scores of patients were similar to those of monozygotic twins. However, prophylactic CNS-directed therapy for leukemia might adversely affect the IQ scores. A further prospective study on larger number of twins is warranted.

국문 초록 (Abstract)

목 적 : 소아에서 혈액 및 종양질환 치료가 성장 및 신경정신기능에 미치는 영향을 알아보고자 본 연구를 시행하였다. 본 연구에서는 대조군을 일란성 쌍생아로 하여 여기에 영향을 주는 많은 인자들은 배제하였다.
방 법 : 1995년 1월부터 2005년 6월까지 전남대학교병원 소아과에서 혈액 및 종양질환으로 치료받은 일란성 쌍생아 7명을 대상으로 하였다[급성 림프구성 백혈병, n=2; DBA, n=2; 중증 재생불량성 빈혈, n=3]. 이들의 진단 시 정중 연령은 5.2세(0.3-15세)이었고, 정중 관찰기간은 7.2년(4.9-10년)이었다. 대조군은 건강한 일란성 쌍생아 형제이었고, DBA를 가진 쌍생아는 1살 어린 동성의 동생을 대조군으로 사용하였다. 환자에게서 신장, 체중을 반복적으로 측정하여, 백분위수 통로를 평가하였다. 인지기능은 K-WISC III를 이용하였는데, 5쌍에서 비교가 가능하였다.
결 과 : 성장은 환자와 건강한 쌍생아 간에 비슷한 양상을 보였다. 진단 시 3명의 환자에서 3-10 백분위수, 2명에서 25-50 백분위수, 그리고 나머지 2명에서는 50-75 백분위수를 보였다. 비만아가 된 1명을 제외하고 나머지 환자들은 추적관찰기간 동안 자신의 백분위수 통로를 유지하였다. IQ 검사 결과를 보면 행동성, 언어성, 전체 지능 지수의 평균치는 각각 88.0, 93.8과 89.8이었고, 대조군에서는 각각 92.2, 97.0과 91.8로 차이가 없었다. 하지만 급성 림프구성 백혈병으로 치료받은 두 명의 환아는 부분적 인지기능 저하가 나타났으며 그 중 방사선조사를 받은 환아에서는 인지기능 저하 외에도 심리적 장애인 주의력결핍 과다행동증후군이 나타났다.
결 론 : 신장과 체중으로 본 성장은 환자나 일란성 쌍생아 형제나 비슷한 소견을 보였다. 환자의 IQ 지수는 쌍생아 대조군과 비슷하였다. 하지만 중추신경계 예방요법을 시행한 백혈병 환자에서는 IQ 지수가 낮아 질 수 있었다. 이러한 치료가 성장 및 정신신경 기능에 미치는 연관성을 정확히 알기 위해서는 더 많은 쌍생아에서의 전향적 연구가 필요할 것이다.

참고문헌 (Reference)

• 1 이기형, "소아의 성장평가 및 성장장애의 진단" 대한소아과학회 46 (46): 1171-1177, 2003
• 2 Chou RH, "Toxicities of total-body irradiation for pediatric bone marrow transplantation" 34 : 843-851, 1996
• 3 Halberg FE, "Total body irradiation and bone marrow transplantation for immunodeficiency disorders in young children" 18 : 114-117, 1990
• 4 Smedler AC, "Sensory- motor and cognitive functioning in children who have undergone bone marrow transplantation" 79 : 613-621, 1990
• 5 Kook H, "Rubella- associated aplastic anemia treated by syngeneic stem cell transplantations" 64 : 303-305, 2000
• 6 Phipps S, "Psychological effects of bone marrow transplantation on children and adolescents: preliminary report of a longitudinal study" 15 : 829-835, 1995
• 7 Pinkel D, "Prevention and treatment of meningeal leukemia in children" 84 : 355-366, 1994
• 8 Davies JH, "Osteopenia, excess adiposity and hyperleptinaemia during 2 years of treatment for childhood acute lymphoblastic leukemia without cranial irradiation" 60 : 358-365, 2004
• 9 Oeffinger KC, "Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study" 21 : 1359-1365, 2003
• 10 Kaleita TA, "Normal neurodevelopment in four young children treated with bone marrow transplantation for acute leukemia or aplastic anemia" 83 : 753-757, 1989
• 11 Chessells JM, "Neurotoxicity in lymphoblastic leukemia: comparison of oral and intramuscular methotrexate and two doses of radiation" 65 : 416-422, 1990
• 12 Simms S, "Neuropsychological outcome of children undergoing bone marrow transplantation" 22 : 181-184, 1998
• 13 Arvidson J, "Neuropsychological functioning after treatment for hematological malignancies in childhood, including autologous bone marrow transplantation" 16 : 9-21, 1999
• 14 Smedler AC, "Neuropsychological deficits in very young bone marrow transplant recipients" 84 : 429-433, 1995
• 15 Butler RW, "Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer" 12 : 2621-2629, 1994
• 16 Mulhern RK, "Memory function in disease-free survivors of childhood acute lymphocytic leukemia given CNS prophylaxis with or without 1,800 cGy cranial irradiation" 6 : 315-320, 1988
• 17 Jannoun L, "Long-term psychological effects of childhood leukemia and its treatment" 4 : 293-308, 1987
• 18 Cool VA, "Long-term neuropsychological risks in pediatric bone marrow transplant: what do we know?" 18 : 45-49, 1996
• 19 Raymond-Speden E, "Intellectual, neuropsychological, and academic functioning in long-term survivors of leukemia" 25 : 59-68, 2000
• 20 Twaddle V, "Intellectual function after treatment for leukaemia or solid tumors" 58 : 949-952, 1983
• 21 Lustig RH, "Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist" 135 : 162-168, 1999
• 22 Birkebaek NH, "Height and weight pattern up to 20 years after treatment for acute lymphocytic leukemia" 79 : 161-164, 1998
• 23 Dalton VK, "Height and weight in children treated for acute lymphoblastic leukemia:relationship to CNS treatment" 21 : 2953-2960, 2003
• 24 Jaruratanasirikul S, "Growth patterns and final height of survivors of childhood leukemia" 17 : 719-726, 2004
• 25 Haupt R, "Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia: a report from the NIH and the CCG" 272 : 1427-1432, 1994
• 26 Meadows AT, "Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukemia treated with children with cranial irradiation" 7 : 1015-1018, 1981
• 27 Whitt JK, "Cranial radiation in childhood acute lymphocytic leukemia. Neuropsychologic sequelae" 138 : 730-736, 1984
• 28 Waber DP, "Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial irradiation requires an accomplice" 13 : 2490-2496, 1995
• 29 Rubenstein CL, "Cognitive functioning in long-term survivors of childhood leukemia: a prospective analysis" 11 : 301-305, 1990
• 30 Cousens P, "Cognitive effects of cranial irradiation in leukaemia: a survey and meta analysis" 29 : 839-852, 1988
• 31 Kramer JH, "Cognitive and adaptive behavior 1 and 3 years following bone marrow transplantation" 19 : 607-613, 1997
• 32 Phipps S, "Cognitive and academic functioning in survivors of pediatric bone marrow transplantation" 18 : 1004-1011, 2000
• 33 Hur YM, "Changes in twinning in South Korea: 1981-2002" 8 : 76-79, 2005
• 34 Langer T, "CNS late-effects after ALL therapy in childhood. part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory" 38 : 320-328, 2002
• 35 Murphy AJ, "Body composition in children in remission from acute lymphoblastic leukemia" 83 : 70-74, 2006
• 36 Schriock EA, "Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia" 9 : 400-405, 1991
• 37 Shin MS, "A standardization study of the Korean version of learning disability evaluation scale" 38 : 784-793, 1999
• 38 Kramer JH, "A prospective study of cognitive functioning following low dose cranial radiation for bone marrow transplantation" 90 : 447-450, 1992
• 39 Williams J, "A comparison of neuropsychological and psychosocial functioning after prophylactic treatment for childhood leukemia in monozygotic twins" 14 : 289-296, 1992
• 40 Brown RT, "A 3-year follow up of the intellectual and academic functioning of children receiving central nervous system prophylactic chemotherapy for leukemia" 17 : 392-398, 1996